Clinical Trial Update: LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating LY4268989 in adults with moderately to severely active ulcerative colitis and is currently recruiting. The sponsor is Eli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LY4268989

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate | Phase 2 | Status: RECRUITING